Recent 13F filings as of September 2025 show that 167 institutional investors hold a position in Viridian Therapeutics, Inc.\DE (NASDAQ:VRDN).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| FMR LLC | 30 Sep, 2025 | 12,249,355 | 10,552 | 0.09% | $264,341,081.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 5,428,521 | -92,514 | -1.68% | $117,147,485.00 |
| Deep Track Capital, LP | 30 Sep, 2025 | 5,380,449 | 0 | 0.00% | $116,110,089.00 |
| Kynam Capital Management, LP | 30 Sep, 2025 | 4,427,927 | 0 | 0.00% | $95,554,665.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 4,331,983 | -176,525 | -3.92% | $93,484,193.00 |
| VR Adviser, LLC | 30 Sep, 2025 | 3,882,709 | 0 | 0.00% | $83,788,860.00 |
| Fairmount Funds Management LLC | 30 Sep, 2025 | 3,459,913 | 0 | 0.00% | $74,664,923.00 |
| Commodore Capital LP | 30 Sep, 2025 | 3,200,000 | -1,675,000 | -34.36% | $69,056,000.00 |
| TANG CAPITAL MANAGEMENT LLC | 30 Sep, 2025 | 2,842,925 | 0 | 0.00% | $61,350,322.00 |
| Paradigm Biocapital Advisors LP | 30 Sep, 2025 | 2,609,353 | -132,223 | -4.82% | $56,309,838.00 |
| STATE STREET CORP | 30 Sep, 2025 | 2,554,166 | 740 | 0.03% | $55,118,902.00 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 30 Sep, 2025 | 2,418,104 | -477,161 | -16.48% | $52,184.00 |
| Novo Holdings A/S | 30 Sep, 2025 | 2,380,000 | 0 | 0.00% | $51,360,400.00 |
| MAVERICK CAPITAL LTD | 30 Sep, 2025 | 2,212,701 | -44,309 | -1.96% | $47,750,088.00 |
| Eversept Partners, LP | 30 Sep, 2025 | 1,924,306 | 21,767 | 1.14% | $41,526,523.00 |
| ALLIANCEBERNSTEIN L.P. | 30 Sep, 2025 | 1,859,458 | -84,562 | -4.35% | $40,127,104.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 1,766,187 | 25,573 | 1.47% | $38,120,267.00 |
| BAKER BROS. ADVISORS LP | 30 Sep, 2025 | 1,744,406 | 0 | 0.00% | $37,644,281.00 |
| LOOMIS SAYLES & CO L P | 30 Sep, 2025 | 1,550,328 | 211,856 | 15.83% | $33,456,078.00 |
| PERCEPTIVE ADVISORS LLC | 30 Sep, 2025 | 1,462,400 | 1,014,893 | 226.79% | $31,558,592.00 |